← Back to Search

Immediate communication education and support group for Neonatal Hearing Loss

N/A
Waitlist Available
Led By Nicole Marrone, PhD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to test the effectiveness of a community health worker intervention to expand access to hearing health care among older adults facing health disparities.

Eligible Conditions
  • Neonatal Hearing Loss
  • Hearing Loss

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean frequency of communication strategy use as measured at eight weeks post baseline for each of a series of study-specific strategies taught in the intervention
Secondary study objectives
Mean number of hearing health actions taken and number of people who took each hearing health action at eight weeks post baseline
Other study objectives
Communication function with partner: Mean frequency and severity of communication-related challenges as measured by a series of study-specific questions at eight weeks post baseline
Mean confidence in communication management at eight weeks post baseline as measured by a series of study-specific questions
Mean value for hearing-specific health-related quality of life at eight weeks post baseline as measured by a series of study-specific questions, some of which are adapted from the Self Assessment of Communication

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate communication education and support groupExperimental Treatment1 Intervention
Group II: WaitlistActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
534 Previous Clinical Trials
159,414 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
352 Previous Clinical Trials
181,069 Total Patients Enrolled
1 Trials studying Neonatal Hearing Loss
236 Patients Enrolled for Neonatal Hearing Loss
Nicole Marrone, PhDPrincipal InvestigatorUniversity of Arizona
~12 spots leftby Nov 2025